# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price target from...
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate ...
Raymond James analyst Steven Seedhouse maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price ...
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price target from...
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of...